康哲药业新交所IPO获中国证监会备案

Core Viewpoint - China Medical System Holdings Limited (康哲药业控股有限公司) has received approval from the China Securities Regulatory Commission (中国证监会) for its overseas issuance and listing, indicating a significant step towards its planned IPO on the Singapore Stock Exchange [1]. Group 1 - The company is planning to list through an introduction method on the Singapore Stock Exchange [1].